Search Results - Lor, Mary, BSc

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial

    Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial by Kennedy, Glen A, MBBS, Varelias, Antiopi, PhD, Vuckovic, Slavica, PhD, Le Texier, Laetitia, PhD, Gartlan, Kate H, PhD, Zhang, Ping, MD, Thomas, Gethin, PhD, Anderson, Lisa, BBiomedSc, Boyle, Glen, PhD, Cloonan, Nicole, PhD, Leach, Justine, BN, Sturgeon, Elise, BN, Avery, Judy, BHlthSc, Olver, Stuart D, BSc, Lor, Mary, BSc, Misra, Ashish K, MBBS, Hutchins, Cheryl, PhD, Morton, A James, MBBS, Durrant, Simon TS, MBBS, Subramoniapillai, Elango, MBBS, Butler, Jason P, MMedSci, Curley, Cameron I, MBBS, MacDonald, Kelli P A, PhD, Tey, Siok-Keen, MBBS, Hill, Geoffrey R, Prof

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector

    A 13.2 mg epinephrine intranasal spray demonstrates comparable pharmacokinetics, pharmacodynamics, and safety to a 0.3 mg epinephrine autoinjector by Dworaczyk, David A., Hunt, Allen L., Di Spirito, Mike, Lor, Mary, Dretchen, Kenneth L., Lamson, Michael J., Pollock, Jonathan, Ward, Thelma

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: